Search Results - "van der Ploeg, H"

Refine Results
  1. 1
  2. 2

    Orexigenic Action of Peripheral Ghrelin Is Mediated by Neuropeptide Y and Agouti-Related Protein by Chen, H. Y, Trumbauer, M. E, Chen, A. S, Weingarth, D. T, Adams, J. R, Frazier, E. G, Shen, Z, Marsh, D. J, Feighner, S. D, Guan, X.-M, Ye, Z, Nargund, R. P, Smith, R. G, Van der Ploeg, L. H. T, Howard, A. D, MacNeil, D. J, Qian, S

    Published in Endocrinology (Philadelphia) (01-06-2004)
    “…Ghrelin, a stomach-derived orexigenic hormone, has stimulated great interest as a potential target for obesity control. Pharmacological evidence indicates that…”
    Get full text
    Journal Article
  3. 3

    Peptidomimetic Regulation of Growth Hormone Secretion by Smith, Roy G, Van der Ploeg, Lex H. T, Howard, Andrew D, Feighner, Scott D, Cheng, Kang, Hickey, Gerard J, Wyvratt, Matthew J, Fisher, Mike H, Nargund, Ravi P, Patchett, Arthur A

    Published in Endocrine reviews (01-10-1997)
    “…I. Introduction II. Identification of Peptidomimetic GH Secretagogues A. Mechanism of action of GHRH, GHRP-6, and somatostatin B. In vitro assays III…”
    Get full text
    Journal Article
  4. 4

    Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans by Cully, Doris F, Vassilatis, Demetrios K, Liu, Ken K, Paress, Philip S, Van der Ploeg, Lex H. T, Schaeffer, James M, Arena, Joseph P

    Published in Nature (London) (20-10-1994)
    “…The avermectins are a family of macrocyclic lactones used in the control of nematode and arthropod parasites. Ivermectin (22,23-dihydroavermectin B1a) is…”
    Get full text
    Journal Article
  5. 5

    Sisyphus cooling and amplification by a superconducting qubit by Grajcar, M, van der Ploeg, S. H. W, Izmalkov, A, Il'ichev, E, Meyer, H.-G, Fedorov, A, Shnirman, A, Schön, Gerd

    Published in Nature physics (01-08-2008)
    “…Laser cooling of atoms paved the way for remarkable achievements in quantum optics, including Bose-Einstein condensation and trapping in optical lattices…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Value of health-related quality of life to predict disability course in multiple sclerosis by VISSCHEDIJK, M. A. J, UITDEHAAG, B. M. J, KLEIN, M, VAN DER PLOEG, E, COLLETTE, E. H, VLEUGELS, L, PFENNINGS, L. E. M. A, HOOGERVORST, E. L. J, VAN DER PLOEG, H. M, POLMAN, C. H

    Published in Neurology (14-12-2004)
    “…To determine the value of health-related quality of life (HRQoL) to predict change in disability status in patients with multiple sclerosis (MS). Over a 5-year…”
    Get full text
    Journal Article
  8. 8

    The prognostic value of cognitive functioning in the survival of patients with high-grade glioma by KLEIN, M, POSTMA, T. J, TAPHOORN, M. J. B, AARONSON, N. K, VANDERTOP, W. P, MULLER, M, VAN DER PLOEG, H. M, HEIMANS, J. J

    Published in Neurology (23-12-2003)
    “…The authors studied cognitive functioning as a potential predictor of survival in 68 newly diagnosed patients with high-grade glioma. In a combined Cox…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Counselling increases physical activity behaviour nine weeks after rehabilitation by van der Ploeg, H P, Streppel, K R M, van der Beek, A J, van der Woude, L H V, Vollenbroek-Hutten, M M R, van Harten, W H, van Mechelen, W

    Published in British journal of sports medicine (01-03-2006)
    “…Background: For people with disabilities, a physically active lifestyle can reduce the risk of secondary health problems and improve overall functioning…”
    Get full text
    Journal Article
  11. 11

    Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening by Mollema, E. D., Snoek, F. J., Heine, R. J., Van Der Ploeg, H. M.

    Published in Diabetic medicine (01-08-2001)
    “…Aims  To define clinically relevant cut‐off points for severe fear of self‐injecting (FSI) and self‐testing (FST) (phobia) in insulin‐treated patients with…”
    Get full text
    Journal Article
  12. 12

    Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: Psychological comorbidity and general well-being by Mollema, E.D, Snoek, F.J, Adèr, Herman J, Heine, R.J, van der Ploeg, H.M

    Published in Journal of psychosomatic research (01-11-2001)
    “…Objective: To examine psychological functioning and self-management behaviours of Dutch adult patients with insulin-requiring diabetes mellitus suffering from…”
    Get full text
    Journal Article
  13. 13

    Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial by van Der Ven, N. C. W., Hogenelst, M. H. E., Tromp-Wever, A. M. E., Twisk, J. W. R., van Der Ploeg, H. M., Heine, R. J., Snoek, F. J.

    Published in Diabetic medicine (01-11-2005)
    “…Aims  To assess the effects of cognitive behavioural group training (CBGT) on glycaemic control, diabetes self‐efficacy and well‐being in Type 1 diabetes…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma by POSTMA, T. J, KLEIN, M, AARONSON, N. K, HEIMANS, J. J, VERSTAPPEN, C. C. P, BROMBERG, J. E. C, SWENNEN, M, LANGENDIJK, J. A, TAPHOORN, M. J. B, SCHELTENS, P, SLOTMAN, B. J, VAN DER PLOEG, H. M

    Published in Neurology (09-07-2002)
    “…Abnormalities on CT or MRI and neuropsychological performance in patients with low-grade glioma, with (n = 23) or without (n = 16) prior cerebral radiotherapy,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs by Jacques, Vincent, Czarnik, Anthony W., Judge, Thomas M., Van der Ploeg, Lex H. T., DeWitt, Sheila H.

    “…Therapeutics developed and sold as racemates can exhibit a limited therapeutic index because of side effects resulting from the undesired enantiomer (distomer)…”
    Get full text
    Journal Article
  19. 19

    Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade by Hagan, M M, Rushing, P A, Pritchard, L M, Schwartz, M W, Strack, A M, Van Der Ploeg, L H, Woods, S C, Seeley, R J

    “…Overexpression of agouti-related peptide (AgRP), an endogenous melanocortin (MC) 3 and 4 receptor antagonist (MC3/4-R), causes obesity. Exogenous…”
    Get more information
    Journal Article
  20. 20